Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"></td><td align="center">Grade I-II</td><td align="center">Grade III-IV</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Nausea</td><td align="center">5</td><td align="center">0</td></tr><tr><td align="left">Abdominal pain</td><td align="center">5</td><td align="center">0</td></tr><tr><td align="left">Alopecia</td><td align="center">2</td><td align="center">0</td></tr><tr><td align="left">Fatigue</td><td align="center">6</td><td align="center">0</td></tr><tr><td align="left">Neutropenia</td><td align="center">0</td><td align="center">0</td></tr><tr><td align="left">Thrombocytopenia</td><td align="center">0</td><td align="center">0</td></tr><tr><td align="left">Catheter infection</td><td align="center">0</td><td align="center">1</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Toxicities observed in ten patients treated with adjuvant intraperitoneal pemetrexed combined with intravenous cisplatin following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.

Gastroenterology Research and Practice

tab2

Table 2

Table 2: Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma 

Table 2 | Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma 